North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on November 9, 2026

2 hours ago

FlashPath Announces Commercial Agreement with Experimental Pathology Laboratories for FlashAE Platform

Indeterminate EIN Presswire

3 hours ago

Locklear Dentistry Maintains 350 Perfect 5-Star Reviews, Named Among Greensboro's Best Dentists by Patients

Indeterminate EIN Presswire

an hour ago

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues

Indeterminate GlobeNewswire

an hour ago

Vireo Growth Inc. Completes Acquisition of FLUENT Corp.

Indeterminate GlobeNewswire

an hour ago

Biodexa provides R&D Update

Indeterminate GlobeNewswire

an hour ago

SAB BIO to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

an hour ago

Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026

Indeterminate GlobeNewswire

an hour ago

Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Indeterminate GlobeNewswire

an hour ago

New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

an hour ago

Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

Indeterminate GlobeNewswire

an hour ago

Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire

an hour ago

Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder

Indeterminate GlobeNewswire

an hour ago

Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Santa Ana Bio Presents Preclinical Data on SAB05, a CD40-Targeted Glucocorticoid Antibody-Drug Conjugate, at ACR Convergence 2026

Indeterminate GlobeNewswire

an hour ago

NKGen Biotech to Present Long-Term Follow-Up of Troculeucel in Moderate Alzheimer’s Disease at CTAD 2026

Indeterminate GlobeNewswire

an hour ago

Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement

Indeterminate GlobeNewswire

an hour ago

Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement

Indeterminate GlobeNewswire

an hour ago

Novastra Therapeutics Reports Further Encouraging Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at SITC 2026

Indeterminate GlobeNewswire

an hour ago

Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026

Indeterminate GlobeNewswire

an hour ago

Prime Medicine to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire